Parnax Lab Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
Parnax Lab has a total shareholder equity of ₹716.9M and total debt of ₹806.4M, which brings its debt-to-equity ratio to 112.5%. Its total assets and total liabilities are ₹1.9B and ₹1.2B respectively. Parnax Lab's EBIT is ₹184.7M making its interest coverage ratio 3.2. It has cash and short-term investments of ₹18.8M.
Anahtar bilgiler
112.5%
Borç/özkaynak oranı
₹806.39m
Borç
| Faiz karşılama oranı | 3.2x |
| Nakit | ₹18.77m |
| Eşitlik | ₹716.95m |
| Toplam yükümlülükler | ₹1.17b |
| Toplam varlıklar | ₹1.89b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 506128's short term assets (₹754.3M) do not cover its short term liabilities (₹818.3M).
Uzun Vadeli Yükümlülükler: 506128's short term assets (₹754.3M) exceed its long term liabilities (₹352.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 506128's net debt to equity ratio (109.9%) is considered high.
Borcun Azaltılması: 506128's debt to equity ratio has increased from 104.1% to 112.5% over the past 5 years.
Borç Kapsamı: 506128's debt is not well covered by operating cash flow (19.7%).
Faiz Kapsamı: 506128's interest payments on its debt are well covered by EBIT (3.2x coverage).